Delivery Order SPE2DB20D3111-SPE2DB25FA6MM
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,392.21 firm fixed-price delivery order is for XIFAXAN 550 MG TABLET 60S, with a completion date of August 15, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $28,524.31 delivery order to provide XIFAXAN 550 mg tablets to the Defense Logistics Agency (DLA). The contract is a firm fixed-price arrangement with a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a range of pharmaceutical products and medical...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XIFAXAN 550 mg tablets over a period ending on September 23, 2024. The $40,062.50 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,333.94 Firm Fixed Price Delivery Order is for the supply of XIFAXAN 550 MG Tablets, a specialty pharmaceutical product. The contract has a completion date of November 5, 2024 and was awarded on November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,808.21, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a delivery order (DO) and firm fixed price (FFP) pricing type, with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,906.15 Firm Fixed Price Delivery Order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,533.02 firm-fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, with a completion date of November 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $5,183.38 firm fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets, a prescription medication, to support DLA's medical supply needs. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,146.83 contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of XIFAXAN 550 mg tablets. The contract has a total ceiling value of $22,603.81 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical products and medical supplies to support military...